Hudson Bay Capital Management
ORIC icon

Hudson Bay Capital Management’s Oric Pharmaceuticals ORIC Stock Holding History

Hudson Bay Capital Management’s Portfolio ORIC Stock Details ORIC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$157K Buy
+12,390
New +$141K ﹤0.01% 1128
2025
Q1 		– Sell
-120,000
Closed -$968K – 1430
2024
Q4 		$968K Buy
+120,000
New +$1.1M ﹤0.01% 755

Other funds holding ORIC

NI
Nextech Invest Zurich, Switzerland $1.42B AUM 304.47% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
SOCM
SR One Capital Management Wayne, Pennsylvania $915M AUM 209.71% 1-Year Est. Return
P
Pfizer New York $239M AUM 232.47% 1-Year Est. Return
Alkeon Capital Management
Alkeon Capital Management New York $59.5B AUM 51.63% 1-Year Est. Return
VA
VR Adviser New York $2.68B AUM 422.73% 1-Year Est. Return
NMC
NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return

Hudson Bay Capital Management's ORIC Position: Q1 2026 in Review

Hudson Bay Capital Management opened a new position in Oric Pharmaceuticals (ORIC) in Q1 2026: 12,390 shares worth $157K. The stake represents ﹤0.01% of the portfolio and ranks #1128 among its holdings. This is a return to the name: Hudson Bay Capital Management previously reported a position in ORIC as recently as Q4 2024.

Hudson Bay Capital Management first reported a position in ORIC in Q4 2024 and has held it in 2 quarters since. The position peaked at $968K in Q4 2024. 182 funds tracked by Wall St. Rank hold ORIC as of Q1 2026.

  • Hudson Bay Capital Management held 12,390 shares of Oric Pharmaceuticals worth $157K as of Q1 2026.
  • Oric Pharmaceuticals was a new Hudson Bay Capital Management position in Q1 2026.
  • Oric Pharmaceuticals made up ﹤0.01% of Hudson Bay Capital Management's portfolio in Q1 2026, its #1128 holding.
  • Hudson Bay Capital Management first reported a position in Oric Pharmaceuticals in Q4 2024 and has held it in 2 quarters since.
  • Hudson Bay Capital Management's Oric Pharmaceuticals position peaked at $968K in Q4 2024.
  • 182 funds tracked by Wall St. Rank held Oric Pharmaceuticals as of Q1 2026.

Based on Hudson Bay Capital Management's 13F filing for Q1 2026, filed 13 May 2026.